A PEER-REVIEWED JOURNAL OF RESEARCH AND CLINICAL MEDICINEISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

The Anemia Syndrome in Contemporary Women: an Unsolved Worldwide Problem. A Therapeutic Approach

DOI:10.31550/1727-2378-2020-19-8-20-24
For citation: Radzinsky V.E., Solovyeva A.V., Fedotov N.G. The Anemia Syndrome in Contemporary Women: an Unsolved Worldwide Problem. A Therapeutic Approach. Doctor.Ru. 2020; 19(8): 20–24. (in Russian). DOI: 10.31550/1727-2378-2020-19-8-20-24:

Objective of the Review: To set forth the frequency and prevalence of the anemia syndrome in non-pregnant and pregnant women and approaches to treating this disorder.

Key Points: Anemia syndrome is the most common health problem in contemporary women. The leading cause of iron deficiency in women of reproductive age is abnormal uterine bleeding (AUB). Anemia in women significantly reduces their ability to work and quality of life, and increases the rates and severity of complications in pregnant women and parturients. It is also a significant contributor to maternal mortality and fetal and neonatal morbidity. Treating anemia in pregnant women presents certain challenges. In the period between the first trimester and delivery, there is an 8-fold increase in the requirement for iron; therefore, hemoglobin levels return to normal slowly. The active ingredient of Ferrum Lek is a ferric hydroxide polymaltose complex, which is as effective as medications containing ferrous sulfate, but is significantly better tolerated by patients and easier to use. The active transport of iron allows its controlled absorption from the polymaltose complex, minimizing the risk of an increase in serum levels of iron not bound to transferrin. This ensures that this medication is very safe and eliminates the risk of overdose or poisoning.

Conclusion: Anemia syndrome is the most common type of homeostatic imbalance in women of reproductive age. It most often results from frequent and abundant uterine bleeding (AUB). Therefore, an obstetrician-gynecologist plays the leading role in identifying menstrual disorders and choosing therapies to reduce blood loss. A gynecologist will also work with an internist (hematologist) in treating iron deficiency anemia.

Contributions: Dr. V.E. Radzinsky developed the concept of the article, collected information, and participated in composing the article, approved the final version submitted for publication. Dr. A.V. Solovyeva collected information, wrote the review, and participated in composing the article. N.G. Fedotov collected information.

Conflict of interest: The authors declare that they do not have any conflict of interests.

V.E. Radzinsky — Peoples’ Friendship University of Russia (a Federal Government Autonomous Educational Institution of Higher Education); 6 Miklouho-Maclay St., Moscow, Russian Federation 117198. eLIBRARY.RU SPIN: 4507-7510. http://orcid.org/0000-0003-4956-0466. E-mail: radzinsky@mail.ru

A.V. Solovyeva (Corresponding author) — Peoples’ Friendship University of Russia (a Federal Government Autonomous Educational Institution of Higher Education); 6 Miklouho-Maclay St., Moscow, Russian Federation 117198. eLIBRARY.RU SPIN: 4961-4466. http://orcid.org 0000-0001-6711-1563. E-mail: av_soloveva@mail.ru

N.G. Fedotov — Peoples’ Friendship University of Russia (a Federal Government Autonomous Educational Institution of Higher Education); 6 Miklouho-Maclay St., Moscow, Russian Federation 117198. E-mail: nk.fedotov@mail.ru

Доктор.ру

Received: 09.07.2020

Accepted: 27.10.2020

LITERATURE
  1. Kassebaum N.J., GBD 2013 Anemia Collaborators. The Global Burden of Anemia. Hematol. Oncol. Clin. North Am. 2016; 30(2): 247–308. DOI: 10.1016/j.hoc.2015.11.002
  2. Toyokuni S. Mysterious link between iron overload and CDKN2A/2B. J. Clin. Biochem. Nutr. 2011; 48(1): 46–9. DOI: 10.3164/jcbn.11-001FR
  3. Van der Veen B.S., De Winther M.P.J., Heeringa P. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid. Redox Signal. 2009; 11(11): 2899–937. DOI: 10.1089/ars.2009.2538
  4. Crichton R., Danielson B.G., Geisser P. et al. Iron therapy with special emphasis on intravenous administration. London — Boston: Uni-Med Verlag AG; 2008. 96 p.
  5. Silverberg D.S., ed. Anemia. Croatia: In-Tech; 2012. 440 p
  6. Hurrell R., Egli I. Iron bioavailability and dietary reference values. Am. J. Clin. Nutr. 2010; 91(5): S1461–7. DOI: 10.3945/ajcn.2010.28674F
  7. Crichton R. Iron absorption in Mammals, with particular reference to man, and regulation of systemic iron balance. In: Iron metabolism — from molecular mechanisms to clinical consequences. John Wiley & Sons, Ltd.; 2009: 271–7.
  8. Hurrell R., Egli I. Iron bioavailability and dietary reference values // Am. J. Clin. Nutr. 2010. Vol. 91. Р. 1461S–1467SHurrell R., Egli I. Iron bioavailability and dietary reference values // Am. J. Clin. Nutr. 2010. Vol. 91. Р. 1461S–1467S
  9. Beaumont C. Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages. Haematologica. 2010; 95(8): 1233–6. DOI: 10.3324/haematol.2010.025585
  10. Soloviova A.V., Sturov V.G., Radzinsky V.E., eds. Anemias and reproductive health. М.: Status Praesens; 2019. 200 p. (in Russian)
  11. Munro M.G., Critchley H.O.D., Fraser I.S. et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int. J. Gynecol. Obstet. 2018; 143(3): 393–408. DOI: 10.1002/ijgo.12666
  12. Napolitano M., Dolce A., Celenza G. et al. Iron-dependent erythropoiesis in women with excessive menstrual blood loss and women with normal menses. Ann. Hematol. 2014; 93(4): 557–63. DOI: 10.1007/s00277-013-1901-3
  13. Breymann C., Bian X.M., Blanco-Capito L.R. et al. Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region. J. Perinat. Med. 2011; 39(2): 113–21. DOI: 10.1515/jpm.2010.132
  14. Drukker L., Hants Y., Farkash R. et al. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion. 2015; 55(12): 2799–806. DOI: 10.1111/trf.13252
  15. Soliman A.T., De Sanctis V., Yassin M. et al. Growth and grouth hormone-insulin like growth factor-I (GH-IGH-I) axis in chronic anemias. Acta Biomed. 2017; 88(1): 101–11. DOI: 10.23750/abm.v88i1.5744
  16. Xu K., Zhang C.M., Huang L.H. et al. Risk factors for iron deficiency anemia in infants aged 6 to 12 months and its effects on neuropsychological development. Zhongguo Dang Dai Er Ke Za Zhi. 2015; 17(8): 830–6.
  17. Dai A.I., Demiryurek S., Aksoy S.N. et al. Maternal iron deficiency anemia as a risk factor for the development of retinopathy of prematurity. Pediatr. Neurol. 2015; 53(2): 146–50.
  18. Soares M.J., Iqbal K., Kozai K. Hypoxia and placental development. Birth Defects Res. 2017; 109(17): 1309–29. DOI: 10.1002/bdr2.1135
  19. Lelic M., Bogdanovic G., Ramic S. et al. Influence of maternal anemia during pregnancy on placenta and newborn. Med. Arch. 2014; 68(3): 184–7. DOI: 10.5455/medarh.2014.68.184-187
  20. Fraser I.S., Mansour D., Breymann C. et al. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int. J. Gynaecol. Obstet. 2015; 128(3): 196–200. DOI: 10.1016/j.ijgo.2014.09.027
  21. Lozoff B., Jimenez E., Smith J.B. Double burden of iron deficiently in infancy and low socioeconomic status: a longitudinal analysis of cognitive test scores to age 19 years. Arch. Pediatr. Adolesc. Med. 2006; 160(11): 1108–13. DOI: 10.1001/archpedi.160.11.1108
  22. Khaskheli M.N., Baloch S., Sheeba A. et al. Iron deficiency anaemia is still a major killer of pregnant women. Pak. J. Med. Sci. 2016; 32(3): 630–4. DOI: 10.12669/pjms 323.9557
  23. Tort J., Rozenberg P., Traoré M. et al. Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey. BMC Pregnancy Childbirth. 2015; 15: 235. DOI: 10.1186/s12884-015-0669-y
  24. Mirza F.G., Abdul-Kadir R., Breymann C. et al. Impact and management of iron deficiency and iron deficiency anemia in women’s health. Expert. Rev. Hematol. 2018; 11(9): 727–36. DOI: 10.1080/17474086.2018.1502081
  25. Knol H.M., Mulder A.B., Bogchelman D.H. et al. The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynecologic abnormalities. Am. J. Obstet. Gynecol. 2013; 209(3): 202.e1–7. DOI: 10.1016/j.ajog.2013.05.059
  26. Bernardi L.A., Ghant M.S., Andrade C. et al. The association between subjective assessment of menstrual bleeding and measures of iron deficiency anemia in premenopausal African-American women: a cross-sectional study. BMC Womens Health. 2016; 16(1): 50. DOI: 10.1186/s12905-016-0329-z
  27. Munro M.G., Critchley H.O., Fraser I.S. et al. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil. Steril. 2011; 95(7): 2204–8. DOI: 10.1016/j.fertnstert.2011.03.079
  28. Breymann C., Honegger C., Hösli I. et al. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum. Arch. Gynecol. Obstet. 2017; 296(6): 1229–34. DOI: 10.1007/s00404-017-4526-.
  29. Breymann C., Honegger C., Hösli I. et al. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum. Arch. Gynecol. Obstet. 2017; 296(6): 1229–34. DOI: 10.1007/s00404-017-4526-.
  30. Di Francesco T., Delafontaine L., Philipp E. et al. Iron polymaltose complexes: could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient? Eur. J. Pharm. Sci. 2020; 143: 105180. DOI: 10.1016/j.ejps.2019.105180
  31. Siabani S., Arya M.M., Babakhani M. et al. Determinants of adherence to iron and folate supplementation among pregnant women in West Iran: a population based cross-sectional study. Quality in Primary Care. 2017; 25(3): 157–63.
  32. Muñoz M., Acheson A.G., Auerbach M. et al. International consensus statment on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017; 72(2): 233–47. DOI: 10.1111/anae.13773
  33. Ortiz R., Toblli J.E., Romero J.D. et al. Efficacy and safety of oral iron (III) polymaltose complex versus ferrous sulfate in pregnancy women with iron-deficiency anemia: a multicenter, randomized, controlled study. J. Matern. Fetal Neonatal Med. 2011; 24(11): 1347–52. DOI: 10.3109/14767058.2011.599080

News

30 June 00:00
A New Issue of Doctor.Ru Neurology Psychiatry, Vol. 20, No. 5 (2021), Published

Find original articles and reviews covering various aspects of neurology, psychiatry and the interview with Professor Marina Arkadievna Kinkulkina

28 June 00:00
A New Issue of Doctor.Ru Internal Medicine, Vol. 20, No. 4 (2021), Published

Find original articles and reviews covering various aspects of cardiology, gastroenterology, internal medicine and the interview with Professor Elena Zelikovna Golukhova

 

3 May 17:06
A New Issue of Doctor.Ru Pediatrics, Vol. 20, No. 3 (2021), Published

Find original articles and reviews covering various aspects of pediatrics and the interview with Professor Evgeny Grigorievich Furman

3 May 17:06
A New Issue of Doctor.Ru Endocrinology, Vol. 20, No. 2 (2021), Published

Find original articles and reviews covering various aspects of endocrinology and the interview with Professor Valentin Viktorovich Fadeev

16 April 11:57
Igor Evgenievich Khatkov joined the American Surgical Association

Igor Evgenievich Khatkov, Head of A. S. Loginov Moscow Clinical Scientific and Practical Centre, Chief Oncologist in and for Moscow is now an honoured member of the American Surgical Association.

All news